BECTON, DICKINSON AND COMPANY Expense Breakdown
No Expense Breakdown for BDX on this site yet.
- 2026-06-30: Medical Essentials $826.00M; Connected Care $528.00M; Interventional $502.00M; BioPharma Systems $362.00M.
- 2025-06-30: Medical Essentials $777.00M; Connected Care $498.00M; Interventional $446.00M; BioPharma Systems $342.00M.
Source checked: the stored Expense Breakdown page for BDX.
Expenses by product
Cost of sales: each quarter (3 month)
| Quarter end | Medical Essentials | Connected Care | Interventional | BioPharma Systems |
|---|
| 2026-06-30 | $826.00M | $528.00M | $502.00M | $362.00M |
|---|
| 2025-06-30 | $777.00M | $498.00M | $446.00M | $342.00M |
|---|
Depreciation, Depletion and Amortization: each quarter (3 month)
| Quarter end | Medical Essentials | Connected Care | Interventional | BioPharma Systems |
|---|
| 2026-06-30 | $138.00M | $199.00M | $182.00M | $42.00M |
|---|
| 2025-06-30 | $145.00M | $198.00M | $200.00M | $29.00M |
|---|
Research and development: each quarter (3 month)
| Quarter end | Medical Essentials | Connected Care | Interventional | BioPharma Systems |
|---|
| 2026-06-30 | $49.00M | $102.00M | $70.00M | $18.00M |
|---|
| 2025-06-30 | $44.00M | $74.00M | $63.00M | $18.00M |
|---|
Selling, General and Administrative Expense: each quarter (3 month)
| Quarter end | Medical Essentials | Connected Care | Interventional | BioPharma Systems |
|---|
| 2026-06-30 | $183.00M | $195.00M | $277.00M | $31.00M |
|---|
| 2025-06-30 | $169.00M | $172.00M | $271.00M | $29.00M |
|---|